New Stock Issuance - The new stock issuance for Zhigao Machinery (证券代码: 920101) is priced at 17.41 CNY per share, effective from August 5, 2025[1] - China Heavy Industry (证券代码: 601989) has a cash option declaration period from August 13, 2025[1] - China Shipbuilding (证券代码: 600150) has a buyback request period from August 13 to August 15, 2025[1] Offer and Acquisition Periods - Shenkou Co., Ltd. (证券代码: 002633) has a tender offer period from July 29 to August 27, 2025[1] - ST Kelly (证券代码: 300326) has a tender offer period from July 17 to August 15, 2025[1] - Happiness Blue Ocean (证券代码: 300528) has a significant announcement on July 30, 2025[1] Market Volatility - There are reports of severe abnormal fluctuations for Tibet Tourism (证券代码: 600749) as of July 31, 2025[1] - ST Suwu (证券代码: 600200) also reported significant volatility on July 30, 2025[1] - The stock of ST YaTai (证券代码: 000691) is under observation for abnormal trading activities as of August 5, 2025[1]

Group 1: New Stock Offerings - Shenke Co., Ltd. (002633) has a tender offer period from July 29, 2025, to August 27, 2025[1] - ST Kelly (300326) has a tender offer period from July 17, 2025, to August 15, 2025[1] - ST Zitian (300280) has a tender offer period ending on July 21, 2025[1] Group 2: Market Alerts - Xizang Tourism (600749) reported severe abnormal fluctuations on July 31, 2025[1] - Tianlu Convertible Bonds (110060) announced significant market activity on July 30, 2025[1] - ST Suwu (600200) experienced unusual trading patterns on July 30, 2025[1] Group 3: Additional Announcements - Happiness Blue Ocean (300528) issued a notice on July 30, 2025, regarding market conditions[1] - Common Pharmaceutical (300966) provided updates on August 1, 2025, related to stock performance[1] - Dongjie Intelligent (300486) released a statement on August 1, 2025, concerning market volatility[1]

Group 1 - The stock of Hubei Gongtong Pharmaceutical Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 30% over three consecutive trading days from July 30 to August 1, 2025 [1] - The company's board of directors conducted a verification regarding the abnormal trading situation and confirmed that there are no undisclosed significant information or major matters under planning that could affect the stock price [1][1] - The board also stated that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange's rules, and previous disclosures do not require correction or supplementation [1][1]

Market Overview - As of August 1, the Shanghai Composite Index closed at 3559.95 points, with a decline of 0.37%. The Shenzhen Component Index closed at 10991.32 points, down 0.17%, and the ChiNext Index closed at 2322.63 points, decreasing by 0.24% [1]. Trading Volume Analysis - A total of 1503 stocks saw an increase in average transaction volume, with 31 stocks experiencing a rise of over 50%. Conversely, 3051 stocks reported a decrease in average transaction volume [1]. - Notable stocks with significant increases in average transaction volume include Kecuan Technology, Shenghui Integration, and Zhengzhong Design [1]. Active Stocks by Transaction Volume - The stocks with the highest increase in average transaction volume on August 1 include: - Kecuan Technology: 9.99% increase, average transaction volume of 1014 shares, up 193.10% [3]. - Shenghui Integration: 10.00% increase, average transaction volume of 672 shares, up 191.70% [3]. - Zhengzhong Design: 10.00% increase, average transaction volume of 2134 shares, up 168.74% [3]. Active Stocks by Transaction Count - The stocks with the highest increase in transaction count on August 1 include: - Anzheng Fashion: -1.69% change, with 68,433 transactions, up 1618.56% [2]. - Yingweike: 2.04% change, with 218,079 transactions, up 1082.38% [2]. - Zhongjiabo Chuang: -3.90% change, with 48,487 transactions, up 656.19% [2]. Stocks with Significant Increases in Both Volume and Count - Kecuan Technology stands out with a 9.99% increase, an average transaction volume of 1014 shares (up 193.10%), and a transaction count of 16,921 (up 126.52%) [4]. - Other notable stocks include: - Jiejia Weichuang: 20.00% increase, average transaction volume of 838 shares (up 130.45%), and 57,709 transactions (up 121.19%) [4]. - Riyi Electronics: 10.01% increase, average transaction volume of 846 shares (up 113.00%), and 25,112 transactions (up 161.72%) [4].

Group 1 - The company announced a share buyback program, having repurchased a total of 197,500 shares as of July 31, 2025, which represents 0.17% of its current total share capital [1]

共同药业8月1日交易公开信息 | 买/ 卖 | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | --- | --- | | 买一 | 招商证券股份有限公司银川北京中路证券营业部 | 1890.37 | 0.00 | | 买二 | 东方财富证券股份有限公司拉萨东环路第二证券营业 | 859.78 | 568.59 | | | 部 | | | | 买三 | 东方财富证券股份有限公司拉萨团结路第二证券营业 | 790.87 | 988.54 | | | 部 | | | | 买四 | 东方财富证券股份有限公司拉萨东环路第一证券营业 | 764.44 | 182.67 | | | 部 | | | | 买五 | 东方财富证券股份有限公司拉萨团结路第一证券营业 | 752.91 | 159.50 | | | 部 | | | | 卖一 | 国信证券股份有限公司北京分公司 | 91.37 | 4336.79 | | 卖二 | 华鑫证券有限责任公司上海陆家嘴证券营业部 | 3.87 | 3545.11 | | 卖三 | 开源证券股份有限公司西安西大街证券营业部 | 1.95 | 276 ...

| 证券代码：300966 | 证券简称：共同药业 | 公告编号：2025-039 | | --- | --- | --- | | 转债代码：123171 | 转债简称：共同转债 | | 湖北共同药业股份有限公司 关于回购公司股份的进展公告 截至 2025 年 7 月 31 日，公司本次通过股份回购专用证券账户以集中竞价交易 方式累计回购公司股份 197,500 股，占公司当前总股本的 0.17%，最高成交价为 16.05 元/股，最低成交价为 13.15 元/股，成交总金额为 3,029,925.00 元（不含交易费用）。 公司本次回购股份符合相关法律法规的要求和公司既定的回购股份方案。 二、其他说明 公司回购股份的时间、回购股份数量、集中竞价交易的委托时间及交易价格等 均符合《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》及本公司回 购股份方案的相关规定。具体如下： 1、公司未在下列期间内回购公司股份： （1）自可能对本公司股票交易价格产生重大影响的重大事项发生之日或者在决 策过程中，至依法披露之日内； （2）中国证监会和深圳证券交易所规定的其他情形。 本公司及董事会全体成员保证信息披露内容的 ...

共同药业公告，公司股票于2025年7月30日、7月31日、2025年8月1日连续三个交易日收盘价格涨幅累计 超过30%。公司董事会对公司控股股东、实际控制人及公司管理层进行了核查，发现公司目前经营情况 及内外部经营环境未发生重大变化，也不存在应披露而未披露的重大事项。股票异常波动期间，公司控 股股东、实际控制人不存在买卖公司股票的情形。公司拟定于2025年8月29日披露《2025年半年度报 告》。 ...

| 证券代码：300966 | 证券简称：共同药业 公告编号：2025-040 | | --- | --- | | 转债代码：123171 | 转债简称：共同转债 | 湖北共同药业股份有限公司 关于公司股票交易异常波动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的具体情况 湖北共同药业股份有限公司（以下简称"公司"）股票于 2025 年 7 月 30 日、7 月 31 日、2025 年 8 月 1 日连续三个交易日收盘价格涨幅偏离值累计超过 30%，根据 深圳证券交易所相关规定，属于股票交易异常波动的情形。 二、公司关注并核实的情况 针对公司股票交易异常波动的情况，公司董事会对公司控股股东、实际控制人 及公司管理层就相关事项进行了核查，现就有关情况说明如下： 1、公司未发现前期披露的信息存在需要更正、补充之处； 2、公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较大 影响的未公开重大信息； 3、公司目前经营情况及内外部经营环境未发生重大变化； 5、股票异常波动期间，公司控股股东、实际控制人不存在买卖公司股票的情形。 ...

Group 1 - The assisted reproductive industry is experiencing a strong upward trend, with companies such as HanShang Group, FuYuan Pharmaceutical, and LiDeMan reaching their daily price limit [1] - Other companies in the sector, including GongTong Pharmaceutical, DaJia WeiKang, SiChuang YiHui, BoTuo Bio, BeiRui Gene, and MaiDi Technology, also saw significant increases in their stock prices [1]